Tetanus, diphtheria, and pertussis are three serious bacterial diseases that were once common causes of severe illness and death. Today, routine immunization has dramatically reduced their incidence, but these infections continue to pose a threat—particularly to infants, older adults, and individuals who are not fully vaccinated.
Vaccination remains the most effective way to prevent these potentially life-threatening diseases.
Tetanus is caused by Clostridium tetani, an anaerobic, Gram-positive, spore-forming bacterium found naturally in soil, dust, and animal manure.
Unlike many infectious diseases, tetanus is not spread from person to person. Infection occurs when bacterial spores enter the body through deep or contaminated wounds, particularly those contaminated with soil or manure.
Once inside the body, the bacteria produce a powerful neurotoxin that affects the nervous system.
Tetanus is characterized by painful muscle stiffness and spasms that progressively worsen.
Classic symptoms include:
Even with modern medical care, tetanus carries a mortality rate of at least 10%.
Most cases occur in adults over 50 years of age, largely because immunity decreases over time if booster vaccinations are not maintained.
Diphtheria is caused by Corynebacterium diphtheriae, a Gram-positive bacillus transmitted through respiratory droplets or direct contact with infected skin lesions.
The disease primarily affects the upper respiratory tract.
The hallmark feature is pseudomembranous pharyngitis, in which a thick gray membrane forms over the throat and tonsils.
This membrane can:
Thanks to widespread vaccination, diphtheria has become extremely rare in the United States, with no confirmed cases reported for more than a decade.
Pertussis is caused by Bordetella pertussis, a highly contagious Gram-negative bacterium spread through respiratory droplets produced by coughing and sneezing.
The incubation period is typically one to three weeks, meaning symptoms often do not appear until several weeks after exposure.
The illness initially resembles a common cold, making early diagnosis difficult.
Symptoms include:
This stage is known as the catarrhal phase.
After one to two weeks, the disease progresses to the paroxysmal phase, characterized by severe coughing fits.
Typical features include:
Without treatment, pertussis may lead to:
Infants younger than one year of age are at the highest risk for severe illness and death from pertussis.
Ironically, babies are often infected by parents, older siblings, grandparents, or caregivers who have only mild cold-like symptoms and may not realize they have pertussis.
Because of this, maintaining community (herd) immunity above 90% through vaccination is critical for protecting infants who are too young to be fully vaccinated.
Several vaccine formulations are available depending on age.
The DTaP vaccine contains:
It is recommended for children from 2 months through 6 years of age.
The Tdap vaccine contains:
It is recommended for:
The Td vaccine protects against:
It does not contain pertussis protection and is commonly used for routine adult booster vaccinations every ten years.
Children receive a five-dose DTaP series at the following ages:
Following completion of the series, protection against pertussis is approximately 98% during the first year, although immunity gradually decreases over time.
Adults who have never been vaccinated require a three-dose primary series, with:
Afterward, adults should receive a Td or Tdap booster every 10 years to maintain protection against tetanus and diphtheria.
Pregnancy presents a unique opportunity to protect newborns before they are old enough to receive their own vaccines.
Current recommendations advise one dose of Tdap during every pregnancy, regardless of previous vaccination history.
Maternal antibodies cross the placenta and provide passive immunity that helps protect infants during their first few months of life, when they are most vulnerable to severe pertussis.
The need for tetanus prophylaxis depends on both the type of wound and the person’s vaccination history.
Individuals with an uncertain vaccination history or who have received fewer than three tetanus-containing vaccine doses should receive a tetanus vaccine (Td or Tdap).
For wounds that are:
Individuals with an incomplete or unknown vaccination history should receive:
TIG provides immediate passive protection while the vaccine stimulates long-term immunity.
Following exposure to pertussis, vaccination and antibiotics both play important roles.
Anyone who is unvaccinated or under-vaccinated should receive an age-appropriate DTaP or Tdap vaccine.
In addition, all household contacts and individuals at high risk should receive preventive antibiotic treatment.
High-risk groups include:
Recommended antibiotics include:
Close contacts of someone diagnosed with diphtheria should receive:
Recommended antibiotic options include:
These measures help eliminate bacterial carriage and prevent further transmission.
